Combination Treatment For Methamphetamine Use Disorder Shows Promise in NIH Study
January 14, 2021
January 14, 2021
WASHINGTON, Jan. 14 (TNSJou) -- The U.S. Department of Health and Human Services' National Institutes of Health issued the following news release:
A combination of two medications, injectable naltrexone and oral bupropion, was safe and effective in treating adults with moderate or severe methamphetamine use disorder in a double-blind, placebo-controlled Phase III clinical trial. The findings suggest this combination therapy may be a promising addition to current approaches to t . . .
A combination of two medications, injectable naltrexone and oral bupropion, was safe and effective in treating adults with moderate or severe methamphetamine use disorder in a double-blind, placebo-controlled Phase III clinical trial. The findings suggest this combination therapy may be a promising addition to current approaches to t . . .